Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CME GROUP INC. Director's Dealing 2014

May 22, 2014

29871_dirs_2014-05-22_b43ddf80-d17b-4a92-b2cd-58b69faa72a7.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CME GROUP INC. (CME)
CIK: 0001156375
Period of Report: 2014-05-22

Reporting Person: Piell Hilda Harris (SR MD and Chief HR Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2014-05-22 Common Stock Class A M 1500 $56.87 Acquired 22635 Direct
2014-05-22 Common Stock Class A S 1500 $70 Disposed 21135 Direct
2014-05-22 Common Stock Class A M 1145 $54.37 Acquired 22280 Direct
2014-05-22 Common Stock Class A S 1145 $70 Disposed 21135 Direct
2014-05-22 Common Stock Class A M 2085 $54.3 Acquired 23220 Direct
2014-05-22 Common Stock Class A S 2085 $70 Disposed 21135 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2014-05-22 Non-Qualified Stock Option (right to buy) $56.87 M 1500 Disposed 2019-09-15 Common Stock Class A (1500) Direct
2014-05-22 Non-Qualified Stock Option (right to buy) $54.37 M 1145 Disposed 2021-09-15 Common Stock Class A (1145) Direct
2014-05-22 Non-Qualified Stock Option (right to buy) $54.3 M 2085 Disposed 2020-09-15 Common Stock Class A (2085) Direct

Footnotes

F1: This sale was completed pursuant to the terms of a pre-arranged trading plan established in accordance with Rule 10b5-1.

F2: As of 9/15/2013, this option vested with respect to 100% of the granted number of shares covered by the option.

F3: These options were granted on September 15, 2011. They vest over a four-year period, with 25% vesting one year after the grant date and 25% vesting on that same date in each of the following three years, subject to acceleration or termination in certain circumstances.

F4: These options were granted on September 15, 2012. They vest over a four-year period, with 25% vesting one year after the grant date and 25% vesting on that same date in each of the following three years, subject to acceleration or termination in certain circumstances.